Cyclin-dependent kinase 4/6 activity is a critical determinant of pre-replication complex assembly

W. A. Braden, A. K. McClendon, E. S. Knudsen

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Cyclin-dependent kinases (CDKs) are important in regulating cell cycle transitions, particularly in coordinating DNA replication. Although the role of CDK2 activity on the replication apparatus has been extensively studied, the role of CDK4/6 in DNA replication control is less understood. Through targeted inhibition of CDK4/6 activity, we demonstrate that CDK4/6 kinase activity promotes cdc6 and cdt1 expression, and pre-replication complex (pre-RC) assembly in cycling cells. Conversely, CDK2 inhibition had no effect on the pre-RC assembly. The inhibition of pre-RC assembly is dependent on a functional retinoblastoma (RB) protein, which mediates downstream effects. As such, CDK4/6 inhibition has minimal effect on the replication apparatus in the absence of RB. The requirement of CDK4/6 was further interrogated using cells lacking D-type cyclins, in which replication complexes form normally, and correspondingly CDK4/6 inhibition had no effect on cell cycle or replication control. However, in the absence of D-type cyclins, CDK2 inhibition resulted in the attenuation of cdc6 and cdt1 levels, suggesting overlapping roles for CDK4/6 and CDK2 in regulating replication protein activity. Finally, CDK4/6 inhibition prevented the accumulation of cdc6 and cdt1 as cells progressed from mitosis through the subsequent G1. Combined, these studies indicate that CDK4/6 activity is important in regulating the expression of these critical mediators of DNA replication.

Original languageEnglish (US)
Pages (from-to)7083-7093
Number of pages11
JournalOncogene
Volume27
Issue number56
DOIs
StatePublished - Nov 27 2008

Fingerprint

Cyclin-Dependent Kinase 6
Cyclin-Dependent Kinase 4
DNA Replication
Cyclin D
Cell Cycle
Retinoblastoma Protein
Cyclin-Dependent Kinases
Retinoblastoma
Mitosis
Phosphotransferases
Proteins

Keywords

  • Cancer
  • CDK
  • Cyclin
  • Pre-RC
  • Tumor suppressor

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Cyclin-dependent kinase 4/6 activity is a critical determinant of pre-replication complex assembly. / Braden, W. A.; McClendon, A. K.; Knudsen, E. S.

In: Oncogene, Vol. 27, No. 56, 27.11.2008, p. 7083-7093.

Research output: Contribution to journalArticle

Braden, W. A. ; McClendon, A. K. ; Knudsen, E. S. / Cyclin-dependent kinase 4/6 activity is a critical determinant of pre-replication complex assembly. In: Oncogene. 2008 ; Vol. 27, No. 56. pp. 7083-7093.
@article{e0fb2d1ff60348be9c0395e6e6ad852a,
title = "Cyclin-dependent kinase 4/6 activity is a critical determinant of pre-replication complex assembly",
abstract = "Cyclin-dependent kinases (CDKs) are important in regulating cell cycle transitions, particularly in coordinating DNA replication. Although the role of CDK2 activity on the replication apparatus has been extensively studied, the role of CDK4/6 in DNA replication control is less understood. Through targeted inhibition of CDK4/6 activity, we demonstrate that CDK4/6 kinase activity promotes cdc6 and cdt1 expression, and pre-replication complex (pre-RC) assembly in cycling cells. Conversely, CDK2 inhibition had no effect on the pre-RC assembly. The inhibition of pre-RC assembly is dependent on a functional retinoblastoma (RB) protein, which mediates downstream effects. As such, CDK4/6 inhibition has minimal effect on the replication apparatus in the absence of RB. The requirement of CDK4/6 was further interrogated using cells lacking D-type cyclins, in which replication complexes form normally, and correspondingly CDK4/6 inhibition had no effect on cell cycle or replication control. However, in the absence of D-type cyclins, CDK2 inhibition resulted in the attenuation of cdc6 and cdt1 levels, suggesting overlapping roles for CDK4/6 and CDK2 in regulating replication protein activity. Finally, CDK4/6 inhibition prevented the accumulation of cdc6 and cdt1 as cells progressed from mitosis through the subsequent G1. Combined, these studies indicate that CDK4/6 activity is important in regulating the expression of these critical mediators of DNA replication.",
keywords = "Cancer, CDK, Cyclin, Pre-RC, Tumor suppressor",
author = "Braden, {W. A.} and McClendon, {A. K.} and Knudsen, {E. S.}",
year = "2008",
month = "11",
day = "27",
doi = "10.1038/onc.2008.319",
language = "English (US)",
volume = "27",
pages = "7083--7093",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "56",

}

TY - JOUR

T1 - Cyclin-dependent kinase 4/6 activity is a critical determinant of pre-replication complex assembly

AU - Braden, W. A.

AU - McClendon, A. K.

AU - Knudsen, E. S.

PY - 2008/11/27

Y1 - 2008/11/27

N2 - Cyclin-dependent kinases (CDKs) are important in regulating cell cycle transitions, particularly in coordinating DNA replication. Although the role of CDK2 activity on the replication apparatus has been extensively studied, the role of CDK4/6 in DNA replication control is less understood. Through targeted inhibition of CDK4/6 activity, we demonstrate that CDK4/6 kinase activity promotes cdc6 and cdt1 expression, and pre-replication complex (pre-RC) assembly in cycling cells. Conversely, CDK2 inhibition had no effect on the pre-RC assembly. The inhibition of pre-RC assembly is dependent on a functional retinoblastoma (RB) protein, which mediates downstream effects. As such, CDK4/6 inhibition has minimal effect on the replication apparatus in the absence of RB. The requirement of CDK4/6 was further interrogated using cells lacking D-type cyclins, in which replication complexes form normally, and correspondingly CDK4/6 inhibition had no effect on cell cycle or replication control. However, in the absence of D-type cyclins, CDK2 inhibition resulted in the attenuation of cdc6 and cdt1 levels, suggesting overlapping roles for CDK4/6 and CDK2 in regulating replication protein activity. Finally, CDK4/6 inhibition prevented the accumulation of cdc6 and cdt1 as cells progressed from mitosis through the subsequent G1. Combined, these studies indicate that CDK4/6 activity is important in regulating the expression of these critical mediators of DNA replication.

AB - Cyclin-dependent kinases (CDKs) are important in regulating cell cycle transitions, particularly in coordinating DNA replication. Although the role of CDK2 activity on the replication apparatus has been extensively studied, the role of CDK4/6 in DNA replication control is less understood. Through targeted inhibition of CDK4/6 activity, we demonstrate that CDK4/6 kinase activity promotes cdc6 and cdt1 expression, and pre-replication complex (pre-RC) assembly in cycling cells. Conversely, CDK2 inhibition had no effect on the pre-RC assembly. The inhibition of pre-RC assembly is dependent on a functional retinoblastoma (RB) protein, which mediates downstream effects. As such, CDK4/6 inhibition has minimal effect on the replication apparatus in the absence of RB. The requirement of CDK4/6 was further interrogated using cells lacking D-type cyclins, in which replication complexes form normally, and correspondingly CDK4/6 inhibition had no effect on cell cycle or replication control. However, in the absence of D-type cyclins, CDK2 inhibition resulted in the attenuation of cdc6 and cdt1 levels, suggesting overlapping roles for CDK4/6 and CDK2 in regulating replication protein activity. Finally, CDK4/6 inhibition prevented the accumulation of cdc6 and cdt1 as cells progressed from mitosis through the subsequent G1. Combined, these studies indicate that CDK4/6 activity is important in regulating the expression of these critical mediators of DNA replication.

KW - Cancer

KW - CDK

KW - Cyclin

KW - Pre-RC

KW - Tumor suppressor

UR - http://www.scopus.com/inward/record.url?scp=58149234010&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149234010&partnerID=8YFLogxK

U2 - 10.1038/onc.2008.319

DO - 10.1038/onc.2008.319

M3 - Article

C2 - 18776921

AN - SCOPUS:58149234010

VL - 27

SP - 7083

EP - 7093

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 56

ER -